Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @SjogrensUMCG
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @SjogrensUMCG
-
Our abatacept trial for primary
#Sjögren s syndrome, out this week in new journal@TheLancetRheum - not perhaps the results we were hoping for, but that's real research!https://twitter.com/TheLancetRheum/status/1224667051106717696 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Take home message of our
@TheLancetRheum paper is that we cannot recommend abatacept treatment for amelioration of systemic Sjögren's syndrome disease activity, although improvements in ESSDAI and physician global disease activity were observed earlier with abatacept.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
...also many thanks to the multidisciplinary team that made this possible!
@TheLancetRheumHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Good morning! We're proud to announce our Lancet Rheumatology article is online, examining the use of abatacept for treatment of early, active Sjögren's syndrome! Huge congratulations to first author
@Jolienvn for her years of dedication.https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(19)30160-2/fulltext …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Germinal centers found in the salivary glands of Sjögren's patients are associated with more severe disease-but how do you define them histologically? Nakshbandi et al from
@SjogrensUMCG kick off 2020 by suggesting you should use Bcl6!https://onlinelibrary.wiley.com/doi/epdf/10.1111/odi.13276 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Recruiting a 4 year post-doc! Project with Prof. Rob Coppes, Dr. Marco DeMaria and Dr. Sarah Pringle (all UMCG) using iPS cell technology and senolytics to rescue radiation induced SG damage - spread the word if you know anyone?https://twitter.com/springles82/status/1211659103476555788 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
2019 is nearly done! Time for the annual Christmas Brunch of the Sjögrens Syndrome research group
From the eyes of Prof Kroesepic.twitter.com/lCV5UtxUVy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sjögren’s Expertise Center Groningen proslijedio/la je Tweet
Packed lecture theatre for this symposium in
#UMCG, showing just how much need there is for discussion about the side effects of checkpoint inhibitors!pic.twitter.com/XD9ONkYyil
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sjögren’s Expertise Center Groningen proslijedio/la je Tweet
Really chuffed this collaboration between
@SjogrensUMCG and @umcgmdl was fruitful and thought provokinghttps://academic.oup.com/ibdjournal/advance-article/doi/10.1093/ibd/izz295/5643745 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Are senescent epithelial progenitor and/or stem cells a common feature across inflammatory diseases? Wang et al have a first look in the intestines of patients with Crohn's diseasehttps://twitter.com/springles82/status/1200042949314301952 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The
@univgroningen is 1 of 3 sites in NL to have a proton irradiation facility! great promo video from funding body@kwf_nl, featuring Prof. Coppes, explaining why this is so importanthttps://twitter.com/springles82/status/1197921944588488704 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Sjögren’s Expertise Center Groningen proslijedio/la je Tweet
In patients with Sjogren's, Ianalumab, a dual-mode of action biologic combining BAFF receptor inhibition with B cell depletion, showed significant response in ESSDAI, a disease activity index, but did not seem to improve most PROs such as fatigue
#ACR19@RheumNowpic.twitter.com/l5UFwOjt2C
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Multiple SS-clinical trial results presented at
#ACR19. The challenge to identify responders remains! Lots of interest for our abatacept follow-up data (week 48) presented by Jolien!pic.twitter.com/ayhnCLeiWs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sjögren’s Expertise Center Groningen proslijedio/la je Tweet
Vaccinate your immune checkpoint inhibitor patients for flu and pneumonia! Urban legend that you have to avoid!
@CCalabreseDO@LCalabreseDO@drdavidliew#ACR19Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great SSF study group meeting
@ACR2019@SjogrensOrg with interesting talks and Jolien receiving her abstract award! Well done!pic.twitter.com/l2SuzjlT7h
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
And she’s done! Anniek van Roon, PhD, after her excellent thesis defense today: Raynaud s phenomenon - mirror of autoimmune disease
pic.twitter.com/sUDfIoeRVO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This week is the International Congress of Immunology, in Beijing, China. Here’s Xiaoyan Wang (PhD student), concentrating in the questions session after her oral presentation! She talked about senescent salivary gland progenitor cells in Sjögren’s syndrome - Well done!
#IUISpic.twitter.com/VedliaHmHO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Celebration Cakes!
#umcg Department of Rheumatology and Clinical Immunology is a@eular_org Center of Excellence in Rheumatology Research! Team work makes the dream workpic.twitter.com/1LoQ5LocSU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.